Management of multinodular goiter in Germany (Papillon 2005): Do the approaches of thyroid specialists and primary care practitioners differ?

NuklearMedizin

Volumn 46, Issue 3, 2007, Pages 65-75

  Dietlein, Markus ^a   Wegscheider, K ^b   Vaupel, R ^c   Schmidt, M ^a   Schicha, M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Goiter; Iodine; Levothyroxine; Primary care; Questionnaire; Radioiodine therapy; Thyroid

Indexed keywords

CALCITONIN; IODINE; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROTROPIN;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HEALTH CARE PERSONNEL; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL SPECIALIST; NODULAR GOITER; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; QUESTIONNAIRE; SCINTIGRAPHY; THYROTROPIN BLOOD LEVEL; TREATMENT PLANNING;

CALCITONIN; COMBINED MODALITY THERAPY; FAMILY PRACTICE; GERMANY; GOITER, NODULAR; HEALTH SURVEYS; HUMANS; INTERNAL MEDICINE; PHYSICIANS, FAMILY; PROBABILITY; QUESTIONNAIRES; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE;

EID: 34249940310     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1160/nukmed-0068     Document Type: Article

References (43)

1. Al-Suliman NN, Ryttov NF, Qvist N et al. Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome. Eur J Surg 1997; 163: 13-20.
2. Becker D, Bair HJ, Becker W et al. Thyroid autonomy with color-coded image-directed Doppler sonography: internal hypervascularization for the recognition of autonomous adenomas. J Clin Ultrasound 1997; 25: 63-69.
3. Bennedbaek FN, Perrild H, Hegedüs L. Diagnosis and treatment of solitary thyroid nodule. Results of a European survey. Clin Endocrinol (Oxf) 1999; 50: 357-363.
4. Bennedbaek FN, Hegedüs L. Management of the solitary thyroid nodule. Results of a North American survey. J Clin Endocrinol Metab 2000; 85: 2493-2498.
5. Berghout A, Wiersinga WM, Smits NJ et al. Interrelationships between age, thyroid volume, thyroid nodularity, and thyroid function in patients with sporadic non-toxic goiter. Am J Med 1990; 89: 602-608.
6. Bonnema SJ, Bertelsen H, Mortensen J et al. The feasibility of high dose iodine-131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function. J Clin Endocrinol Metab 1999; 84: 3636-3641.
7. Bonnema SJ, Bennedbsk FN, Wiersinga WM et al. Management of the nontoxic multinodular goitre: a European questionnaire study. Clin Endocrinol (Oxf) 2000; 53: 5-12.
8. Bonnema SJ, Bennedbæk FN, Ladenson PW et al. Management of the nontoxic multinodular goiter: a North American survey. J Clin Endocrinol Metab 2002; 87: 112-117.
9. Castro MR, Caraballo PJ, Morris JC. Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis. J Clin Endocrinol Metab 2002; 87: 4154-4159.
10. Cooper DS, Doherty GM, Haugen BR et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16: 1-33.
11. Diehl LA, Garcia V, Bonnema SJ et al. Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey. J Clin Endocrinol Metab 2005; 90: 117-123.
12. Dietlein M, Dressler J, Grünwald F et al. Guideline for in vivo and in vitro procedures for thyroid diseases (version 2). Nuklearmedizin 2003; 42: 109-115.
13. Dietlein M, Moka D, Schmidt M et al. Prevention, screening and therapy of thyroid diseases and their cost-effectiveness. Nuklearmedizin 2003; 42: 181-189.
14. Dietlein M, Dressler J, Grünwald F et al. Guideline for radioiodine therapy for benign thyroid diseases (version 3). Nuklearmedizin 2004; 43: 217-220.
15. Dietlein M, Kobe C, Schmidt M et al. The incidentaloma of the thyroid: over- or underuse of diagnostic procedures for an epidemiologic finding? Nuklearmedizin 2005; 44: 213-224.
16. Dietlein M, Dederichs B, Kobe C et al. Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery. Nuklearmedizin 2006; 45: 21-34.
17. From G, Mellemgaard A, Knudsen N et al. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid 2000; 10: 697-700.
18. Führer D, Mügge C, Paschke R. Questionnaire on management of nodular thyroid disease (Annual Meeting of the Thyroid Section of the German Society of Endocrinology 2003). Exp Clin Endocrinol Diabetes 2005; 113: 152-159.
19. 99mTc-uptake in autonomous thyroid tissue in Germany since the 1970s. Nuklearmedizin 2006; 45: 122-125.
20. Gotthardt M, Rubner C, Bauhofer A et al. What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy? Nuklearmedizin 2006; 45: 206-212.
21. Grussendorf M, Vaupel R, Reiners C et al. and the LISA-study group. The LISA trial - a randomized, double-blind, placebo-controlled four-arm study of 1,000 patients with nodular goiter in Germany. Study design and first results of feasibility. Med Klinik 2005; 100: 542-546.
22. Hampel R. Aktuelle Iodversorgung in Deutschland. In: Dietlein M, Schicha H. Schilddrüse 2003 - Zufallsbefund Schilddrüsenknoten - Latente Schilddrüsenfunktionsstörungen. Berlin: De Gruyter 2004, 52-61.
23. Hegedüs L, Hansen BM, Knudsen N et al. Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. Br Med J 1988; 297: 661-662.
24. Kahaly GJ, Dietlein M. Cost estimation of thyroid disorders in Germany. Thyroid 2002; 12: 909-914.
25. Karges W, Dralle H, Raue F et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112: 52-58.
26. Koch W, Rosa F, Knesewitsch P et al. Guideline on radiation protection in medicine requires documentation of radioiodine therapy and follow-up: What are the benefits of an electronic database? Nuklearmedizin 2005; 44: 49-55.
27. Le Moli R, Wesche MF, Tiel-Van Buul MM et al. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin Endocrinol (Oxf) 1999; 50: 783-789.
28. Luster M, Führer D, Engelhardt C et al. Prävalenz von szintigraphisch heißen, kalten und indifferenten Schilddrüsenknoten bei Patienten mit bekanntem solitärem Herdbefund. Nuklearmedizin 2005; 44: A6-A7.
29. Mazzaferri EL. Management of a solitary thyroid nodule. N Engl J Med 1993; 328: 553-559.
30. Mellemgaard A, From G, Jorgensen T et al. Cancer risk in individuals with benign thyroid disorders. Thyroid 1998; 8: 751-754.
31. 131I activities and radioiodine therapy. Nuklearmedizin 2005; 44: 243-248.
32. 131I-induced release of "cold" iodine stored in the thyroid. Nuklearmedizin 2005; 44: 137-142.
33. Parle JV, Maisonneuve P, Sheppard MC et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001; 358: 861-865.
34. Quadbeck B, Pruellage J, Roggenbuck U et al. Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes 2002; 110: 348-354.
35. Reiners C, Wegscheider K, Schicha H et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 2004; 14: 926-932.
36. Rink T, Bormuth F-J, Schroth H-J et al. Spectrometric assessment of thyroid depth within the radioiodine test. Nuklearmedizin 2005; 44: 192-196.
37. Verschreibungsindex für Pharmazeutika. IMS VIP® 2005. www.imshealth.de.
38. Völzke H, Ludemann J, Robinson DM et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810.
39. Vogt H, Wengenmair H, Kopp J et al. Radioiodine therapy for combined disseminated and nodular thyroid autonomy. Nuklearmedizin 2006; 45: 101-104.
40. Walter MA, Christ-Crain M, Müller B et al. Radioiodine uptake and thyroid hormone levels on or off simultaneous carbimazole medication: A prospective paired comparison. Nuklearmedizin 2005; 44: 33-36.
41. Wémeau J-L, Caron P, Schvartz C et al. Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular non-palpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group. J Clin Endocrinol Metab 2002; 87: 4928-4934.
42. Wesche MF, Tiel-Van Buul MM, Lips P et al. Randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86: 998-1005.
43. Zelmanovitz F, Genro S, Gross J. Suppressive therapy with levothyroxine for solitary thyroid nodules: a double-blind controlled clinical study and cumulative meta-analyses. J Clin Endocrinol Metab 1998; 83: 3881-3885.